BioCatalystWatch
TERNWorkspace / TERN / OverviewCompany library
Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. (TERN)

Website

Featured programme · TERN-801

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Waiting clinical

PreINDP1P2P3FilingApproved

Partner / License out

small molecule

BCR::ABL1 (ABL1 myristoyl pocket)

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

small molecule

GIPR

INDP1P2P3FilingApproved

Historical archive

small molecule

VAP-1

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

TERN PR & News

PR & News

TERN SEC archive